• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GERMANY ALINITY I CA 19-9XR; CA19-9

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GERMANY ALINITY I CA 19-9XR; CA19-9 Back to Search Results
Catalog Number 08P32-20
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/30/2019
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product list 08p32-20, that has a similar us product distributed in the us, list 08p32-21 and 08p32-31.Patient information: no further information is available.Investigation of the customer issue included a review of the complaint text, a search for similar complaints, in-house testing and a review of labeling.Review of tracking and trending reports for the alinity i ca 19-9xr assay did not identify any related trends.An increase in complaint activity associated with the complaint issue was identified for reagent lot 98368fp00.Return testing was not completed as returns were not available.An internal panel was tested with retained kits of reagent lot 98368fp00.Acceptance criteria was met, which indicates acceptable product performance.Manufacturing documentation for the likely cause lot did not identify any issues associated with the complaint issue.Additionally, labeling was reviewed and sufficiently addresses the customer's issue.No systemic issue or deficiency of the alinity i ca 19-9xr assay was identified.
 
Event Description
The customer observed erratic/inconsistent alinity i ca 19-9xr results.The customer indicated a patient has been regularly monitored with consistently increasing ca 19-9 results that ranged from 42 to 647 u/ml.The customer reported that the undiluted result did not match diluted results for the samples collected in august and september.August 2019 sample id 1908330741: undiluted 1164 u/ml and diluted 1:10 278 to 364 u/ml.September 2019 sample id unknown: undiluted 1048 u/ml and diluted 1:10 456 u/ml.No impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I CA 19-9XR
Type of Device
CA19-9
Manufacturer (Section D)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
christian lee
100 abbott park road
dept 09b9, bldg cp01-3
abbott park, IL 60064-3537
224668-294
MDR Report Key9411098
MDR Text Key190120543
Report Number3002809144-2019-01010
Device Sequence Number1
Product Code NIG
Combination Product (y/n)N
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/07/2020
Device Catalogue Number08P32-20
Device Lot Number98368FP00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/13/2019
Initial Date FDA Received12/04/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/01/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-